Findings from the FAMS-T1D study demonstrate that structured goal-setting and achievement significantly enhance self-efficacy and self-care in emerging adults who have type 1 diabetes (T1D).
Findings from a new study from the University of Utah demonstrates significant improvements in self-efficacy and self-care among emerging adults (EAs) managing type 1 diabetes (T1D) through a structured goal-setting intervention. The FAMS (Family/friend Activation to Motivate Self-care)-T1D (FAMS-T1D) program, focusing on tailored coaching and daily support, shows promising results in empowering young adults during the critical transition to independent diabetes management.
The research, published in Frontiers in Clinical Diabetes and Healthcare,1 specifically targets the transitional phase of emerging adulthood, a period marked by significant changes in social and personal responsibilities that can complicate chronic disease management. Study participants reported achieving their daily management goals on 79% of the days, which significantly correlated with improvements in self-efficacy and self-care measures.
The 3-month feasibility trial enrolled 29 EAs aged 18 to 24 years (median age, 21.6 years) with a diagnosis of T1D and who have been using insulin for at least 1 year. The study utilized the FAMS-T1D intervention, which is adapted from a previously successful program designed for type 2 diabetes.2 It involves a combination of monthly coaching and daily text messaging support to foster robust self-management skills through goal-setting and achievement.
The FAMS-T1D intervention consists of 3 components:
It's noted that although the involvement of a SP was optional, most participants elected to include SPs.
Session 1 included goal setting and education on the role of others in diabetes self-management. The EAs were guided to set personalized food or blood glucose management goals, and subsequent sessions involved discussing the progress of goals and an opportunity to adjust or change them, followed by coach-directed skill building to enhance social regulation. Food goals were most frequent across all sessions, followed by blood glucose management goals, although goals involved a mixture of complex and changing behaviors throughout the intervention. Despite frequent adjustments to goal complexity, the high goal achievement rate remained constant.
The authors added, "The lack of relationship between goal change or goal complexity and goal achievement suggests that EAs can alter their goals to increasingly take on the complexity of diabetes management with the assistance of a coach and text support."
The study found that goal achievement was associated with increased confidence and higher self-efficacy and self-care. Interestingly, the study found no significant impact of goal achievement on reducing diabetes distress or lowering hemoglobin A1C levels.
"The results have implications for clinical practice. Integrating tracking of goal progress into clinical practice (eg, through diabetes educator sessions or electronic health records) could assist EAs to maintain goal pursuit for diabetes management. Helping EAs anticipate times of uncertainty (busy times at work, vacations) characteristic of emerging adulthood may be crucial to maintaining goal pursuit," concluded the authors.
References
1. Berg CA, Mansfield JH, Boggess SB, et al. Goal change and goal achievement for emerging adults across the pilot FAMS-T1D intervention for type 1 diabetes. Front Clin Diabetes Healthc. 2024:5:1297422. doi:10.3389/fcdhc.2024.1297422
2. Mayberry LS, Berg CA, Greevy RA, et al. Mixed-methods randomized evaluation of FAMS: a mobile phone-delivered intervention to improve family/friend involvement in adults’ type 2 diabetes self- care. Ann Behav Med. 2021;55(2):165-178. doi:10.1093/abm/kaaa041
Delayed Diagnoses, Oxygen Therapy Use Linked to Worse Outcomes in Patients With Fibrotic ILD
October 21st 2024Posters presented at the CHEST 2024 annual meeting revealed that delays in diagnosing fibrotic interstitial lung disease (ILD) can negatively impact overall survival, while supplemental oxygen therapy may exacerbate clinical burdens through increased rates of acute exacerbations and hospitalizations.
Read More
Sustaining Compassionate Trauma Care Across Communities
September 30th 2024September is National Recovery Month, and we are bringing you another limited-edition month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In our final episode, we speak with Lyndra Bills, MD, and Shari Hutchison, MS.
Listen
FLT3 Inhibitor Gilteritinib May Also Be Effective as ALK Inhibitor in AML
October 20th 2024The case study, which showed prolonged disease control achieved with gilteritinib in a previously-treated patient with AML with an inv(2)(p23q13) translocation, indicates that gilteritinib can also be used as an anaplastic lymphoma kinase (ALK) inhibitor.
Read More
Frameworks for Advancing Health Equity: Community Wellness Centers
September 27th 2024Delia Orosco, MS, director of Community Wellness Centers at Inland Empire Health Plan, shares insight into innovative initiatives provided by the wellness centers and their new mobile mammogram clinics.
Listen